Excessive bone formation in a mouse model of ankylosing spondylitis is associated with decreases in Wnt pathway inhibitors

Arthritis Research and Therapy

Volumn 14, Issue 6, 2012, Pages

  Haynes, Katelin R ^a   Pettit, Allison R ^b   Duan, Ran ^a   Tseng, Hsu Wen ^a   Glant, Tibor T ^c   Brown, Matthew A ^a   Thomas, Gethin P ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; DICKKOPF 1 PROTEIN; OSTEOCALCIN; PROTEOGLYCAN; DKK1 PROTEIN, MOUSE; GLYCOPROTEIN; SIGNAL PEPTIDE; SOST PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANKYLOSING SPONDYLITIS; ARTHRODESIS; ARTICLE; BONE MINERALIZATION; CARTILAGE MATRIX; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE EXPRESSION PROFILING; IMMUNOREGULATION; INFLAMMATION; INTERVERTEBRAL DISK DEGENERATION; MOUSE; NONHUMAN; OSSIFICATION; PROTEIN EXPRESSION; WNT SIGNALING PATHWAY; ANIMAL; BONE DEVELOPMENT; CHEMICALLY INDUCED; DISEASE MODEL; DNA MICROARRAY; GENE ONTOLOGY; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; JOINT; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINE;

ANIMALS; COLLAGEN TYPE I; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION PROFILING; GENE ONTOLOGY; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; JOINTS; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOCALCIN; OSTEOGENESIS; PROTEOGLYCANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPINE; SPONDYLITIS, ANKYLOSING; WNT SIGNALING PATHWAY;

EID: 84869869829     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4096     Document Type: Article

References (46)

1. Ronneberger M, Schett G. Pathophysiology of Spondyloarthritis. Current Rheumatology Reports 2011, 1-5.
2. Appel H, Loddenkemper C, Miossec P. Rheumatoid arthritis and ankylosing spondylitis - pathology of acute inflammation. Clin Exp Rheumatol 2009, 27:S15-19.
3. Maksymowych WP. Disease modification in ankylosing spondylitis. Nat Rev Rheumatol 2010, 6:75-81. 10.1038/nrrheum.2009.258, 20125174.
4. Maksymowych WP, Chiowchanwisawakit P, Clare T, Pedersen SJ, Ostergaard M, Lambert RG. Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: evidence of a relationship between inflammation and new bone formation. Arthritis Rheum 2009, 60:93-102. 10.1002/art.24132, 19116919.
5. Pedersen SJ, Sørensen IJ, Lambert RGW, Hermann K-GA, Garnero P, Johansen JS, Madsen OR, Hansen A, Hansen MS, Thamsborg G, Andersen LS, Majgaard O, Loft AG, Erlendsson J, Asmussen KH, Jurik AG, Møller J, Hasselquist M, Mikkelsen D, Østergaard M. Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor α inhibitors: a study of radiographic progression, inflammation on magnetic resonance imaging, and circulating biomarkers of inflammation, angiogenesis, and cartilage and bone turnover. Arthritis Rheum 2011, 63:3789-3800. 10.1002/art.30627, 22127697.
6. Hammer RE, Maika SD, Richardson JA, Tang J-P, Taurog JD. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human [beta]2m: An animal model of HLA-B27-associated human disorders. Cell 1990, 63:1099-1112. 10.1016/0092-8674(90)90512-D, 2257626.
7. Tran TM, Dorris ML, Satumtira N, Richardson JA, Hammer RE, Shang J, Taurog JD. Additional human beta-microglobulin curbs HLA-B27 misfolding and promotes arthritis and spondylitis without colitis in male HLA-B27-transgenic rats. Arthritis Rheum 2006, 54:1317-1327. 10.1002/art.21740, 16575857.
8. Redlich K, Gortz B, Hayer S, Zwerina J, Kollias G, Steiner G, Smolen JS, Schett G. Overexpression of tumor necrosis factor causes bilateral sacroiliitis. Arthritis Rheum 2004, 50:1001-1005. 10.1002/art.20194, 15022345.
9. Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F, Kollias G. Impaired On/Off Regulation of TNF Biosynthesis in Mice Lacking TNF AU-Rich Elements: Implications for Joint and Gut-Associated Immunopathologies. Immunity 1999, 10:387-398. 10.1016/S1074-7613(00)80038-2, 10204494.
10. Capková J, Ivanyi P. H-2 influence on ankylosing enthesopathy of the ankle (ANKENT). Folia Biologica 1992, 38:258-262.
11. Lories RJU, Matthys P, de Vlam K, Derese I, Luyten FP. Ankylosing enthesitis, dactylitis, and onychoperiostitis in male DBA/1 mice: a model of psoriatic arthritis. Ann Rheum Dis 2004, 63:595-598. 10.1136/ard.2003.013599, 1754976, 15082495.
12. Glant TT, Mikecz K, Arzoumanian A, Poole AR. Proteoglycan-induced arthritis in BALB/c mice. Clinical features and histopathology. Arthritis Rheum 1987, 30:201-212. 10.1002/art.1780300211, 3827960.
13. Bardos T, Szabo Z, Czipri M, Vermes C, Tunyogi-Csapo M, Urban RM, Mikecz K, Glant TT. A longitudinal study on an autoimmune murine model of ankylosing spondylitis. Ann Rheum Dis 2005, 64:981-987. 10.1136/ard.2004.029710, 1755557, 15640265.
14. Baron R, Rawadi G. Targeting the Wnt/β-catenin pathway to regulate bone formation in the adult skeleton. Endocrinology 2007, 148:2635-2643. 10.1210/en.2007-0270, 17395698.
15. Daoussis D, Liossis SN, Solomou EE, Tsanaktsi A, Bounia K, Karampetsou M, Yiannopoulos G, Andonopoulos AP. Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis. Arthritis Rheum 2010, 62:150-158. 10.1002/art.27231, 20039407.
16. Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, Dwyer D, Korb A, Smolen J, Hoffmann M, Scheinecker C, van der Heide D, Landewe R, Lacey D, Richards WG, Schett G. Dickkopf-1 is a master regulator of joint remodeling. Nature Medicine 2007, 13:156-163. 10.1038/nm1538, 17237793.
17. Uderhardt S, Diarra D, Katzenbeisser J, David J-P, Zwerina J, Richards WG, Kronke G, Schett G. Blockade of Dickkopf-1 induces fusion of sacroiliac joints. Ann Rheum Dis 2010, 69:592-597. 10.1136/ard.2008.102046, 19304568.
18. Finnegan A, Grusby MJ, Kaplan CD, O'Neill SK, Eibel H, Koreny T, Czipri M, Mikecz K, Zhang J. IL-4 and IL-12 Regulate proteoglycan-induced arthritis through stat-dependent mechanisms. J Immunol 2002, 169:3345-3352.
19. Gruber HE, Ingram J, Hanley EN. An improved staining method for intervertebral disc tissue. Biotech Histochem 2002, 77:81-83.
20. Chang MK, Raggatt L-J, Alexander KA, Kuliwaba JS, Fazzalari NL, Schroder K, Maylin ER, Ripoll VM, Hume DA, Pettit AR. Osteal tissue macrophages are intercalated throughout human and mouse bone lining tissues and regulate osteoblast function in vitro and in vivo. The J Immunol 2008, 181:1232-1244.
21. Walsh NC, Reinwald S, Manning CA, Condon KW, Iwata K, Burr DB, Gravallese EM. Osteoblast function is compromised at sites of focal bone erosion in inflammatory arthritis. J Bone Miner Res 2009, 24:1572-1585. 10.1359/jbmr.090320, 19338457.
22. Thomas G, Moffatt P, Salois P, Gaumond MH, Gingras R, Godin E, Miao D, Goltzman D, Lanctot C. Osteocrin, a novel bone-specific secreted protein that modulates the osteoblast phenotype. J Biol Chem 2003, 278:50563-50571. 10.1074/jbc.M307310200, 14523025.
23. Duan R, Leo P, Bradbury L, Brown MA, Thomas G. Gene expression profiling reveals a downregulation in immune-associated genes in patients with AS. Ann Rheum Dis 2010, 69:1724-1729. 10.1136/ard.2009.111690, 19643760.
24. Du P, Kibbe WA, Lin SM. lumi: a pipeline for processing Illumina microarray. Bioinformatics 2008, 24:1547-1548. 10.1093/bioinformatics/btn224, 18467348.
25. Simon R, Lam A, Ming-Chung L, Ngan M, Menenzes S, Zhao Y. Analysis of gene expression data using brb-array tools. Cancer Inform 2007, 3:11-17. 2675854, 19455231.
26. Pimentel-Santos F, Ligeiro D, Matos M, Mourao A, Costa J, Santos H, Barcelos A, Godinho F, Pinto P, Cruz M, Fonseca J, Guedes-Pinto H, Branco J, Brown M, Thomas G. Whole blood transcriptional profiling in ankylosing spondylitis identifies novel candidate genes that might contribute to the inflammatory and tissue-destructive disease aspects. Arthritis Res Ther 2011, 13:R57. 10.1186/ar3309, 3132052, 21470430.
27. Calin A, Elswood J. The relationship between pelvic, spinal and hip involvement in ankylosing spondylitis-one disease process or several?. BrJ Rheumatol 1988, 27:393-395.
28. Glant TT, Finnegan A, Mikecz K. Proteoglycan-induced arthritis: immune regulation, cellular mechanisms, and genetics. Crit Rev Immunol 2003, 23:199-250. 10.1615/CritRevImmunol.v23.i3.20, 14584879.
29. Benjamin M, McGonagle D. The enthesis organ concept and its relevance to the spondyloarthropathies. Adv Exp Med Biol 2009, 649:57-70. 10.1007/978-1-4419-0298-6_4, 19731620.
30. Kabasakal Y, Garrett SL, Calin A. The epidemiology of spondylodiscitis in ankylosing spondylitis-a controlled study. Rheumatology 1996, 35:660-663.
31. Cawley MI, Chalmers TM, Kellgren JH, Ball J. Destructive lesions of vertebral bodies in ankylosing spondylitis. Ann Rheum Dis 1972, 31:345-358. 10.1136/ard.31.5.345, 1005943, 4116083.
32. van der Heijde D, Landewe R, Baraliakos X, Houben H, van Tubergen A, Williamson P, Xu W, Baker D, Goldstein N, Braun J. Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis. Arthritis Rheum 2008, 58:3063-3070. 10.1002/art.23901, 18821688.
33. Lories RJU, Derese I, de Bari C, Luyten FP. Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis. Arthritis Rheum 2007, 56:489-497. 10.1002/art.22372, 17265484.
34. Maksymowych WP, Landewé R, Conner-Spady B, Dougados M, Mielants H, van der Tempel H, Poole AR, Wang N, van der Heijde D. Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis. Arthritis Rheum 2007, 56:1846-1853. 10.1002/art.22589, 17530713.
35. Raj PP. Intervertebral disc: anatomy-physiology-pathophysiology-treatment. Pain Practice 2008, 8:18-44. 10.1111/j.1533-2500.2007.00171.x, 18211591.
36. Sims A-M, Timms AE, Bruges-Armas J, Burgos-Vargas R, Chou C-T, Doan T, Dowling A, Fialho RN, Gergely P, Gladman DD, Inman R, Kauppi M, Kaarela K, Laiho K, Maksymowych W, Pointon JJ, Rahman P, Reveille JD, Sorrentino R, Tuomilehto J, Vargas-Alarcon G, Wordsworth BP, Xu H, Brown MA, . International Genetics of Ankylosing Spondylitis Prospective meta-analysis of interleukin 1 gene complex polymorphisms confirms associations with ankylosing spondylitis. Ann Rheum Dis 2008, 67:1305-1309. International Genetics of Ankylosing Spondylitis.
37. Evans DM, Spencer CC, Pointon JJ, Su Z, Harvey D, Kochan G, Opperman U, Dilthey A, Pirinen M, Stone MA, Appleton L, Moutsianis L, Leslie S, Wordsworth T, Kenna TJ, Karaderi T, Thomas GP, Ward MM, Weisman MH, Farrar C, Bradbury LA, Danoy P, Inman RD, Maksymowych W, Gladman D, Rahman P, Morgan A, Marzo-Ortega H, Bowness P, Gaffney K, et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet 2011, 43:761-767. 10.1038/ng.873, 21743469.
38. Strange A, Capon F, Spencer CC, Knight J, Weale ME, Allen MH, Barton A, Band G, Bellenguez C, Bergboer JG, Blackwell JM, Bramon E, Bumpstead SJ, Casas JP, Cork MJ, Corvin A, Deloukas P, Dilthey A, Duncanson A, Edkins S, Estivill X, Fitzgerald O, Freeman C, Giardina E, Gray E, Hofer A, Huffmeier U, Hunt SE, Irvine AD, Jankowski J, et al. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet 2010, 42:985-990. 10.1038/ng.694, 20953190.
39. Doodes PD, Cao Y, Hamel KM, Wang Y, Rodeghero RL, Mikecz K, Glant TT, Iwakura Y, Finnegan A. IFN-γ Regulates the Requirement for IL-17 in Proteoglycan-Induced Arthritis. J Immunol 2010, 184:1552-1559. 10.4049/jimmunol.0902907, 2846113, 20028652.
40. Boldizsar F, Tarjanyi O, Nemeth P, Mikecz K, Glant TT. Th1/Th17 polarization and acquisition of an arthritogenic phenotype in arthritis-susceptible BALB/c, but not in MHC-matched, arthritis-resistant DBA/2 mice. Int Immunol 2009, 21:511-522. 10.1093/intimm/dxp018, 2675029, 19254958.
41. Shen H, Goodall JC, Hill Gaston JS. Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum 2009, 60:1647-1656. 10.1002/art.24568, 19479869.
42. Kenna TJ, Davidson SI, Duan R, Bradbury LA, McFarlane J, Smith M, Weedon H, Street S, Thomas R, Thomas GP, Brown MA. Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive γ/δ T cells in patients with active ankylosing spondylitis. Arthritis Rheum 2012, 64:1420-1429. 10.1002/art.33507, 22144400.
43. Davidson SI, Liu Y, Danoy PA, Wu X, Thomas GP, Jiang L, Sun L, Wang N, Han J, Han H, Visscher PM, Brown MA, Xu H. Association of STAT3 and TNFRSF1A with ankylosing spondylitis in Han Chinese. Ann Rheum Dis 2011, 70:289-292. 10.1136/ard.2010.133322, 21068102.
44. Chen C-H, Lin K-C, Yu DTY, Yang C, Huang F, Chen H-A, Liang T-H, Liao H-T, Tsai C-Y, Wei JCC, Chou C-T. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity. Rheumatology 2006, 45:414-420. 10.1093/rheumatology/kei208, 16287916.
45. Hayer S, Niederreiter B, Nagelreiter I, Smolen J, Redlich K. Interleukin 6 is not a crucial regulator in an animal model of tumour necrosis factor-mediated bilateral sacroiliitis. Ann Rheum Dis 2010, 69:1403-1406. 10.1136/ard.2010.129148, 20498200.
46. Appel H, Ruiz-Heiland G, Listing J, Zwerina J, Herrmann M, Mueller R, Haibel H, Baraliakos X, Hempfing A, Rudwaleit M, Sieper J, Schett G. Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis. Arthritis Rheum 2009, 60:3257-3262. 10.1002/art.24888, 19877044.